KFDA holds information session on foreign inspection of clinical trials in Korea

Published: 2012-11-30 06:59:00

Updated: 2012-11-30 06:59:00

The Korea Food and Drug Administration (KFDA) on Wednesday held its information session at the Korea Pharmaceutical Manufacturers Association, in a bid to help local drug makers cope with the inspection by the U.S. Food and Drug Administration and European Medicines Agency (EMA), when Korean comp...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK